Month: April 2022

Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives

Written by Customer Service on April 8, 2022. Posted in Public Companies.

DURHAM, N.C., April 08, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that TheraSkin coverage now includes three out of the four largest commercial plans in the U.S. along with Medicare and several regional commercial plans. Bioventus’ TheraSkin is a cellular and tissue-based treatment for difficult to heal chronic wounds and this expanded coverage adds more than 17 million medical lives to the existing coverage. The results of Bioventus’ TheraSkin Randomized Controlled Trial (RCT) were published on January 26, 2022 in the International Wound Journal and demonstrated statistically significant improved wound healing when receiving the treatment versus standard of care. This recent publication further supplements the 13 previous...

Medicenna Announces Preclinical Data Highlighting the Potent Anti-Tumor Efficacy of Anti-PD1-IL-2 BiSKIT at the AACR Annual Meeting

Written by Customer Service on April 8, 2022. Posted in Public Companies.

— Anti-PD1-IL-2 BiSKIT (Bi-functional SuperKines for ImmunoTherapy) selectively stimulates anti-cancer immune cells via IL-2 agonism and prevents their exhaustion through PD-1 inhibition — Treatment with anti-PD-1-IL-2 BiSKIT led to statistically significant improvements in tumor growth inhibition and survival compared to the co-administration of its underlying components — Data highlight the versatility of the Superkine platform and the advantages of using a cis-binding approach to enhance the efficacy of checkpoint blockade TORONTO and HOUSTON, April 08, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-oncology company, today announced new preclinical data highlighting the potent anti-tumor efficacy of the next-generation...

Form 8.3 – [CareTech Holdings plc – 07 04 2022] – (CGWL)

Written by Customer Service on April 8, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

TransUnion Completes Acquisition of Verisk Financial Services

Written by Customer Service on April 8, 2022. Posted in Mergers And Acquisitions.

Together, Verisk Financial and TransUnion create a “full wallet view” of consumer spend and produce actionable new insights into consumer behavior for participating customers CHICAGO, April 08, 2022 (GLOBE NEWSWIRE) — TransUnion (NYSE:TRU) announced today that it has completed the acquisition of Verisk Financial Services (“Verisk Financial”), the financial services business unit of Verisk (Nasdaq: VRSK), for $515 million. Leading financial institutions, payment providers and retailers worldwide rely on Verisk Financial for a variety of data, insights, and analytics – in addition to advisory services – to gain a clear perspective on where their businesses stand today and how to best position themselves for future success. Verisk Financial’s leading business, Argus Information & Advisory Services Inc. (“Argus”), provides proprietary...

Cold Chain Market Size, Share, Dynamics, Key Regions and Forecast by 2029 | Cold Chain Industry to Spur Business Opportunities During 2022-2029

Written by Customer Service on April 8, 2022. Posted in Mergers And Acquisitions.

Companies covered in Cold Chain Market are Argo Merchants Group LLC, Americold Logistics LLC., Burris Logistics Inc., Swire Group, Al Rai Logistica K.S.C., Swire Cold Storage, Cold Chain Technologies, Inc., VersaCold Logistics Services, Nichirei Corporation, Lineage Logistics and others Pune, India, April 08, 2022 (GLOBE NEWSWIRE) — The global cold chain market size is expected to grow significantly because of the rising adoption of technologically advanced refrigeration and storage techniques by retailers and storage depots. Thus, this factor can propel market growth in the upcoming years. Fortune Business Insights™ offers this information in its report titled “Cold Chain Market, 2022-2029.“ Cold Chain is a thermal packaging and refrigeration system that protects thermally susceptible goods during travel. It is extensively...

SeaChange Reports Fourth Quarter and Fiscal Year 2022 Financial and Operational Results

Written by Customer Service on April 8, 2022. Posted in Earnings Releases And Operating Results.

– Continued Operating Momentum, with Fiscal Q4 2022 Total Revenue up 20% from Fiscal Q3 2022 and up 67% Year-over-Year– Signed major renewal with Tier 1 Operator in Q4 2022 BOSTON, April 08, 2022 (GLOBE NEWSWIRE) — SeaChange International, Inc. (NASDAQ: SEAC), (“SeaChange” or the “Company”) a leading provider of video delivery, advertising, and emerging streaming platforms, today reported financial and operational results for the fiscal fourth quarter and full-year ended January 31, 2022. Fiscal Fourth Quarter 2022Closed two major renewal and upgrade projects with Tier 1 operators in North America and Latin America, adding over $2 million in one-time product and license revenue as well as long-term commitments for recurring support and services revenue. Secured new business with a North American cable operator that...

DLH to Participate in the Noble Capital Conference

Written by Customer Service on April 8, 2022. Posted in Public Companies.

ATLANTA, April 08, 2022 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, today announced that it will participate in Noble Capital’s 18th Annual Microcap Investor Conference April 20-21, 2022 in Miami, Florida. As part of this event, management will host a webcast presentation at 10:00 a.m. Eastern Time on the 20th. Institutional investors are welcome to participate in one-on-one meetings and, if they do not have a Noble contact, may call or email DLH investor relations for assistance. About DLHDLH (NASDAQ:DLHC) delivers improved health and readiness solutions for federal programs through research, development, and innovative care processes. The Company’s experts in public health, performance evaluation, and health operations...

Fagron publishes agenda 2022 annual general meeting and extraordinary general meeting

Written by Customer Service on April 8, 2022. Posted in Public Companies.

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 8 April 2022 Fagron publishes agenda 2022 annual general meeting and extraordinary general meeting The Board of Directors of Fagron NV (Fagron) invites the holders of shares and subscription rights of Fagron to attend the annual general meeting of shareholders and the extraordinary general meeting of shareholders on Monday 9 May 2022. Both meetings will be held in hybrid format. AgendaThe agenda includes the discussion of the annual report (published today in Dutch), the approval of the annual financial statements and the dividend proposal of €0.20 for the fiscal year 2021, and the proposal for several appointments. As announced earlier, the Board of Directors will propose to appoint Vera Bakker, Ann Desender, and Neeraj Sharma as independent and non-executive directors...

PDS Biotechnology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Written by Customer Service on April 8, 2022. Posted in Public Companies.

FLORHAM PARK, N.J., April 08, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary Versamune® and Infectimune™ T-cell activating technologies, today announced that on April 6, 2022 PDS Biotech granted nonstatutory stock options to (a) Robert Imani, M.D., PhD, PDS Biotech’s Vice President Medical Director to purchase 70,000 shares of PDS Biotech common stock, and (b) Paul Ivany, PDS Biotech’s Senior Director Manufacturing Operations, to purchase 50,000 shares of PDS Biotech’s common stock, in each case, as a material inducement to their employment with PDS Biotech and in accordance with Nasdaq Listing Rule 5635(c)(4) and PDS Biotech’s...

BeyondSpring to Announce Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call on Thursday, April 14, 2022

Written by Customer Service on April 8, 2022. Posted in Public Companies.

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it will report its financial results for the quarter and year ended December 31, 2021 before market open on Thursday, April 14, 2022. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:00 am Eastern Time.Conference Call & Webcast Details: Date: Thursday, April 14Time: 8:00 am Eastern TimeToll Free: 877-451-6152International: 201-389-0879Conference ID: 13728822Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1542381&tp_key=4941bdf92aAbout BeyondSpringHeadquartered in New York City, BeyondSpring...

Month: April 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals